Commit To Purchase Enliven Therapeutics At $17.50, Earn 19.7% Annualized Using Options
Investors eyeing a purchase of Enliven Therapeutics Inc (Symbol: ELVN) shares, but cautious about paying the going market price of $25.91/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in parti
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1275678683-725353d1a3c848f98a6776e5b4f4b8fd.jpg "The Hidden Costs of Owning a Home")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1457735277-845518c00e924402b78a5fc94b1da650.jpg "These Are the Highest-Paid Athletes in the World as of 2024")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1411173624-c572d225369347339d7f260b69f4a476.jpg "Going Back to India to Retire? Read This First")
